Expertise.

Treatment-center economics for advanced-therapy payment, purchasing and expansion decisions.

Two routes lead the practice. Each starts from the decision in front of the client and ends with a deliverable the team can use.

Hospitals and cancer centers running CAR-T, TIL or transplant programs

The question
Whether the program is being paid what its contracts and the Medicare rule support, payer by payer.
What HealthPulse examines
Payer contracts, single-case agreements, outlier thresholds and Revenue Code 891 billing, checked against current CMS baselines.
What you receive
An assessment of payment gaps and financial exposure, with quantified scenarios where the available evidence supports them.
The decision it supports
Which contracts to renegotiate or restructure first, and what the program's forecast should assume.
Where it starts
One payer and one product.
Advanced therapy programs

Life-sciences companies bringing an advanced therapy to market

The question
How coverage policy, billing mechanics and outcomes-based agreements will interact at the state and payer level.
What HealthPulse examines
Coverage policy, provider billing mechanics and outcomes-based agreement terms, for the provider settings that will treat patients.
What you receive
A written assessment of how those terms are likely to pay out at the treating provider, and which terms drive the result.
The decision it supports
Launch planning, coverage-policy positions and agreement design, while the plan can still change.
Where it starts
One product and the setting where it will be given.
Life sciences

Not sure which route fits?

Describe the decision. HealthPulse will say whether it is work the firm should take, including when the answer is no.

Discuss a decision